The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA puts some peptides off limits BPC 157 Complete Guide: Dosing & 2026 Status The Peptide Toolkit FDA Peptide Reclassification 2026: What Researchers Want Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law The Blacklisting of Peptides